iNKT Cell Production of GM-CSF Controls Mycobacterium tuberculosis

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Rothchild, Alissa C ^a,b,c   Jayaraman, Pushpa ^c   Nunes Alves, Cláudio ^c,d,e   Behar, Samuel M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINHO   (Portugal)

^e UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; PATHOLOGY; PERITONEUM MACROPHAGE; TUBERCULOSIS;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T-CELLS; TUBERCULOSIS;

EID: 84893811293     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003805     Document Type: Article

References (54)

1. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, et al. (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372: 691-694.
2. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, et al. (1996) CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol 157: 2795-2803.
3. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
4. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986.
5. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
6. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, et al. (2011) Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12: 966-974.
7. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB, (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230-1237.
8. Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem 287: 8816-8829.
9. Cohen NR, Tatituri RV, Rivera A, Watts GF, Kim EY, et al. (2012) Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 10: 437-450.
10. Brigl M, Tatituri RV, Watts GF, Bhowruth V, Leadbetter EA, et al. (2011) Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 208: 1163-1177.
11. Nakamatsu M, Yamamoto N, Hatta M, Nakasone C, Kinjo T, et al. (2007) Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect 9: 364-374.
12. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L, (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 20: 358-368.
13. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, et al. (2002) CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 8: 588-593.
14. Chackerian A, Alt J, Perera V, Behar SM, (2002) Activation of NKT cells protects mice from tuberculosis. Infect Immun 70: 6302-6309.
15. Sada-Ovalle I, Skold M, Tian T, Besra GS, Behar SM, (2010) Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection. Am J Respir Crit Care Med 182: 841-847.
16. Gansert JL, Kiessler V, Engele M, Wittke F, Rollinghoff M, et al. (2003) Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 170: 3154-3161.
17. Venkataswamy MM, Baena A, Goldberg MF, Bricard G, Im JS, et al. (2009) Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 183: 1644-1656.
18. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM, (2008) Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog 4: e1000239.
19. Sutherland JS, Jeffries DJ, Donkor S, Walther B, Hill PC, et al. (2009) High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis (Edinb) 89: 398-404.
20. Im JS, Kang TJ, Lee SB, Kim CH, Lee SH, et al. (2008) Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections. Clin Immunol 127: 214-224.
21. Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, et al. (2008) Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol 127: 1-6.
22. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB, (1999) Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189: 1973-1980.
23. D'Souza CD, Cooper AM, Frank AA, Ehlers S, Turner J, et al. (2000) A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol 23: 188-193.
24. Sugawara I, Yamada H, Mizuno S, Li CY, Nakayama T, et al. (2002) Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb) 82: 97-104.
25. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, et al. (2000) Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 97: 4204-4208.
26. Nagarajan NA, Kronenberg M, (2007) Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 178: 2706-2713.
27. Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, et al. (2004) Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 114: 1790-1799.
28. Jung YJ, LaCourse R, Ryan L, North RJ, (2002) Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice. J Exp Med 196: 991-998.
29. Martin CJ, Booty MG, Rosebrock TR, Nunes-Alves C, Desjardins DM, et al. (2012) Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 12: 289-300.
30. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
31. Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, et al. (2013) IL-1beta Promotes Antimicrobial Immunity in Macrophages by Regulating TNFR Signaling and Caspase-3 Activation. J Immunol 190: 4196-4204.
32. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 184: 3326-3330.
33. Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, et al. (2006) Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 36: 631-647.
34. Wang X, Bishop KA, Hegde S, Rodenkirch LA, Pike JW, et al. (2012) Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. Journal of Experimental Medicine pp. 987-1000.
35. Denis M, Ghadirian E, (1990) Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages. Immunol Lett 24: 203-206.
36. Bermudez LE, Young LS, (1990) Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J Leukoc Biol 48: 67-73.
37. Denis M, (1991) Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49: 380-387.
38. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, et al. (1993) Cytokine production at the site of disease in human tuberculosis. Infect Immun 61: 3482-3489.
39. Bhattacharyya S, Singla R, Dey AB, Prasad HK, (1999) Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 67: 5597-5603.
40. Hoft DF, Worku S, Kampmann B, Whalen CC, Ellner JJ, et al. (2002) Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 186: 1448-1457.
41. Cowley SC, Elkins KL, (2003) CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 171: 4689-4699.
42. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, et al. (2001) CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167: 2734-2742.
43. Woodworth JS, Wu Y, Behar SM, (2008) Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol 181: 8595-8603.
44. Gonzalez-Juarrero M, Hattle JM, Izzo A, Junqueira-Kipnis AP, Shim TS, et al. (2005) Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 77: 914-922.
45. Szeliga J, Daniel DS, Yang CH, Sever-Chroneos Z, Jagannath C, et al. (2008) Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) 88: 7-20.
46. Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, et al. (2013) Anti-GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis. J Immunol 190: 3959-3966.
47. Hegde S, Chen X, Keaton JM, Reddington F, Besra GS, et al. (2007) NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol 81: 1224-1235.
48. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
49. Cohen NR, Brennan PJ, Shay T, Watts GF, Brigl M, et al. (2012) Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 14: 90-99.
50. Bendelac A, Hunziker RD, Lantz O, (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 184: 1285-1293.
51. Exley MA, Bigley NJ, Cheng O, Shaulov A, Tahir SM, et al. (2003) Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 110: 519-526.
52. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
53. Chiba A, Cohen N, Brigl M, Brennan PJ, Besra GS, et al. (2009) Rapid and reliable generation of invariant natural killer T-cell lines in vitro. Immunology 128: 324-333.
54. Park SH, Roark JH, Bendelac A, (1998) Tissue-specific recognition of mouse CD1 molecules. J Immunol 160: 3128-3134.